NCT05237180

Brief Summary

Hearing comprehension under complex listening conditions is considered to be the central complaint of everyday life for patients with cochlear implants. Localization is one of the cues for listening comprehension. However, only few studies have investigated the effect of spatial localization training on listening comprehension performance in noise. None of these studies correspond to the desire to purpose training by speech therapists while using affordable equipment. The main objective of this study is to evaluate the effect of a spatial localization training protocol in cochlear bi-implanted subjects with post-lingual deafness on their ability to understand in noise. 2 groups of 10 subjects each will be recruited: a patient group and a control group. The patient group will undergo 8 sessions of spatial localization rehabilitation lasting an average of 45 minutes each. After this programme, the pre-test and post- test results obtained will be compared.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 14, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

February 15, 2022

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

October 20, 2022

Status Verified

January 1, 2022

Enrollment Period

14 days

First QC Date

January 10, 2022

Last Update Submit

October 19, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change of Hearing comprehension performance in noise

    MBAA (Marginal Benefic from Acoustical Amplification) scale. Minimal score = 0 and maximal score =540. minimum score means that the patient is unable to repeat phrases and maximal score means that the patient is able to repeats all phrases.

    10 weeks after inclusion

  • Change of Hearing comprehension performance in noise

    15iSSQ (New 15 items Speech Spatial and qualities of hearing Scale Shoirt Form). Minimum score =0 and maximal score = 150. maximal score means that the patient has a good quality of life and minimum score means that his quality of life is bad. It is a qualitative evaluation.

    10 weeks after inclusion

Study Arms (2)

patient group

EXPERIMENTAL

8 training sessions on spatial localisation

Other: spatial localisation training

control croup

NO INTERVENTION

Non training sessions

Interventions

8 spatial localization training sessions MBAA and SSQ tests before and after training sessions.

patient group

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • post-lingual deafness
  • implanted bilaterally for at least 1 year
  • score ≥ 70 at LAFON scale
  • score ≥ 70 at MBAA scale
  • score ≥ 5/9 at CAP scale
  • good command of the French language
  • accepts to participate in the study

You may not qualify if:

  • do not realize speech reeducation (spatial localisation and speech perception) during the study
  • no change in setting of cochlear implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gcs Crcsi

Sainte-Clotilde, Reunion

Location

MeSH Terms

Conditions

Hearing Loss, Sensorineural

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Justine MAISSON

    GCS CRCSI

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2022

First Posted

February 14, 2022

Study Start

February 15, 2022

Primary Completion

March 1, 2022

Study Completion

March 1, 2022

Last Updated

October 20, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations